Granholm M ,Mckusick BC ,Westerholm FC and Aspegrén JC  (2007)Evaluation of the clinical efficacy and safety of intramuscular and intravenous doses of dexmedetomidine and medetomidine in dogs and their reversal with atipamezole. Veterinary Record 160 ,891–897

Korpivaara M, Laapas K, Huhtinen M, Schöning B and Overall K (2017) Dexmedetomidine oromucosal gel for noise-associated acute anxiety and fear in dogs—a randomised, double-blind, placebo-controlled clinical study. Veterinary Record 180, 356

Gruen M, Case BC, Robertson JB, Campbell S and Korpivaara ME (2020) Evaluation of repeated dosing of a dexmedetomidine oromucosal gel for treatment of noise aversion in dogs over a series of noise events. Veterinary Record  187, 489–489

Hauser H, Campbell S, Korpivaara M et al. (2020) In-hospital administration of dexmedetomidine oromucosal gel for stress reduction in dogs during veterinary visits: A randomized, double-blinded, placebo-controlled study. Journal of Veterinary Behavior 39,77–85

Korpivaara M, Laapas K, Huhtinen M et al.(2016) Dexmedetomidine oromucosal gel for alleviation of acute anxiety and fear associated with noise in dogs. Journal of Veterinary Internal Medicine 30, 1493

Korpivaara M, Huhtinen M, Aspegrén J and Overall K (2021) Dexmedetomidine oromucosal gel reduces fear and anxiety in dogs during veterinary visits: A randomised, double-blind, placebo-controlled clinical pilot study. Veterinary Record 189, e832

Valtolina C, Robben H, Uilenreef J et al. (2009) Clinical evaluation of the efficacy and safety of a constant rate infusion of dexmedetomidine for postoperative pain management in dogs.Veterinary Anaesthesia and Analgesia 36, 369–383